Alpha-MSH decreases core and brain temperature during global cerebral ischemia in rats

Stefan Spulber1, Mihai Moldovan, Mircea Oprica

  • 1Division of Experimental Geriatrics, Neurotec Department, Karolinska Institutet, Novum, 4th floor, SE-141 86 Stockholm, Sweden. Stefan.Spulber@neurotec.ki.se

Neuroreport
|December 25, 2004
PubMed

Insights

Alpha-melanocyte-stimulating hormone (alpha-MSH) reduces brain and core body temperature during cerebral ischemia in rats. This hypothermia may offer neuroprotection against ischemic brain injury.

Area of Science:

  • Neuroscience
  • Physiology
  • Pathology

Background:

  • Glutamate excitotoxicity is a key pathological event in cerebral ischemia.
  • Alpha-melanocyte-stimulating hormone (alpha-MSH) has previously been shown to enhance kainic acid-induced hypothermia.

Purpose of the Study:

  • To investigate the effects of alpha-MSH on core temperature (CT) and brain temperature (BT) during four-vessel occlusion forebrain ischemia.
  • To determine if alpha-MSH influences temperature regulation in sham-operated rats.

Main Methods:

  • Systemic administration of alpha-MSH or saline in a rat model of global cerebral ischemia (four-vessel occlusion).
  • Monitoring of core body temperature (CT) and brain temperature (BT) before, during, and after ischemia and reperfusion.
  • Comparison of temperature changes between alpha-MSH-treated and saline-treated groups, as well as sham-operated controls.

Main Results:

  • Following 10 minutes of cerebral ischemia, brain temperature (BT) was significantly lower in alpha-MSH-injected rats compared to saline-injected controls.
  • After 10 minutes of reperfusion, both core temperature (CT) and brain temperature (BT) remained lower than pre-ischemic levels in alpha-MSH-treated rats.
  • Alpha-MSH did not affect CT or BT in sham-operated rats, indicating its effect is specific to ischemic conditions.

Conclusions:

  • Systemic administration of alpha-MSH induces hypothermia during global cerebral ischemia in rats.
  • The alpha-MSH-induced reduction in brain temperature during ischemia may contribute to its potential neuroprotective effects.
  • Further research is warranted to explore the therapeutic potential of alpha-MSH in mitigating ischemic brain damage.

Related Concept Videos